Patients on 300 mg of sulthiame saw a nearly 40% reduction in apnea episodes in just 12 weeks, offering a promising new drug treatment for obstructive sleep apnea.
Recent study at the European Respiratory Society Congress in Vienna shows women with asthma have higher fetal loss rates and increased fertility treatment.